Literature DB >> 22123077

Epidemiology of major eye diseases leading to blindness in Europe: a literature review.

Elena Prokofyeva1, Eberhart Zrenner.   

Abstract

The objective of this work was to study the epidemiology of major eye diseases leading to blindness in Europe through a systematic literature review. The literature search was performed using the Medline database (PubMed), with MeSH and free text search terms. Inclusion criteria for the studies were: (a) performed on a healthy population of Caucasian origin aged between 50 and 75 years; (b) diagnosed by ophthalmological examination in accordance with the International Classification of Diseases 10; (c) contained a detailed description of the sampling and diagnostic procedures and data resources; (d) sample size>500, and (e) published between 1990 and 2008. The results of 57 studies on the prevalence and incidence of age-related macular degeneration, diabetic retinopathy and glaucoma are reported, providing an up-to-date and comprehensive overview of these diseases in Europe from an epidemiological perspective.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 22123077     DOI: 10.1159/000329603

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  47 in total

1.  Optical coherence tomography angiography characteristics in diabetic patients without clinical diabetic retinopathy.

Authors:  Ian A Thompson; Alia K Durrani; Shriji Patel
Journal:  Eye (Lond)       Date:  2018-12-03       Impact factor: 3.775

2.  Tachyphylaxis during ranibizumab treatment of exudative age-related macular degeneration.

Authors:  Sibel Doguizi; Sengul Ozdek; Selcen Yuksel
Journal:  Int J Ophthalmol       Date:  2015-08-18       Impact factor: 1.779

3.  [Retrospective investigation of anti-VEGF treatment reality and effectiveness in patients with neovascular age-related macular degeneration (AMD) in Germany: treatment reality of ranibizumab for neovascular AMD in Germany].

Authors:  F Ziemssen; N Eter; S Fauser; S Bopp; M Radermacher; Z Hasanbasic; F G Holz
Journal:  Ophthalmologe       Date:  2015-03       Impact factor: 1.059

4.  Phase I clinical trial of SYL040012, a small interfering RNA targeting β-adrenergic receptor 2, for lowering intraocular pressure.

Authors:  Javier Moreno-Montañés; Belén Sádaba; Verónica Ruz; Almudena Gómez-Guiu; Javier Zarranz; María Victoria González; Covadonga Pañeda; Ana Isabel Jimenez
Journal:  Mol Ther       Date:  2013-09-12       Impact factor: 11.454

5.  Induction of vascular endothelial growth factor receptor expression in human umbilical vein endothelial cells after repeated bevacizumab treatment in vitro.

Authors:  Ji Eun Lee; Jin Young Kim; Jae Ho Jung; Dong Hoon Shin; Sung Who Park
Journal:  Int J Ophthalmol       Date:  2017-07-18       Impact factor: 1.779

6.  Label-free nonlinear optical imaging of mouse retina.

Authors:  Sicong He; Cong Ye; Qiqi Sun; Christopher K S Leung; Jianan Y Qu
Journal:  Biomed Opt Express       Date:  2015-02-26       Impact factor: 3.732

7.  Oxidative stress affects retinal pigment epithelial cell survival through epidermal growth factor receptor/AKT signaling pathway.

Authors:  Xiao-Dong Chen; Ming-Yang Su; Tao-Tao Chen; Hai-Yan Hong; Ai-Dong Han; Wen-Sheng Li
Journal:  Int J Ophthalmol       Date:  2017-04-18       Impact factor: 1.779

8.  [Long-term results in neovascular age-related macular degeneration : Changes in visual acuity and geographic atrophy during long-standing anti-VEGF therapy].

Authors:  V Thalgott; N Feucht; C P Lohmann; M Maier
Journal:  Ophthalmologe       Date:  2016-08       Impact factor: 1.059

9.  Analysis of the prevalence of cataracts and glaucoma in systemic lupus erythematosus and evaluation of the rheumatologists' practice for the monitoring of glucocorticoid eye toxicity.

Authors:  L Carli; C Tani; F Querci; A Della Rossa; S Vagnani; C Baldini; R Talarico; A d'Ascanio; R Neri; A G Tavoni; S Bombardieri; M Mosca
Journal:  Clin Rheumatol       Date:  2013-03-03       Impact factor: 2.980

Review 10.  Oxidative stress and potential applications of free radical scavengers in glaucoma.

Authors:  Mutay Aslan; Serdar Dogan; Ertan Kucuksayan
Journal:  Redox Rep       Date:  2013-03-06       Impact factor: 4.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.